Treating EGFR Patients After Tarceva Stops Working
from GRACEcast Radiation Oncology Audio Hosted by cancerGRACE - H. Jack West, MD
Tarceva (erlotinib) has greatly helped EGFR positive lung cancer patients, but eventually it stops working. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center talks about the next generation EGFR inhibitors that may soon become available. February 2014.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of GRACEcast Radiation Oncology Audio?
This episode is 2 minutes long.
When was this GRACEcast Radiation Oncology Audio episode published?
This episode was published on May 19, 2014.
Can I download this GRACEcast Radiation Oncology Audio episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.